Abstract Library

#2159 Hepatic Steatosis Secondary to Peptide Receptor Radionuclide Therapy with Somatostatin Analogue

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) with 177-Lutetium-DOTA-TATE is a therapeutic modality for neuroendocrine tumors. It has some well known side effects, concerning specially the bone marrow (from cytopenias to myelodysplastic syndrome), in addition to mild renal effects. Hepatotoxicity from PRRT is still being studied.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Matheos de Lima B

Authors: Arruda Matheos de Lima B, Gonçalves R, Romano Gaspar P, Linhares Riello de Mello E, Oliveira Albagli R,

Keywords: peptide receptor radionuclide therapy, lutetium, collateral effects, hepatotoxicity, neuroendocrine tumor, hepatic steatosis,

#1552 Liver Transplantation for Gastroenteropancreatic Neuroendocrine Tumors

Introduction: Neuroendocrine tumors (NET) are rare neoplasms and liver transplantation (LT) for hepatic metastases is indicated in selected cases where other therapies have failed.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Figueira E

Authors: Figueira E, Rocha Filho J, Haddad L, Oliveira A, Okubo J,

Keywords: Liver transplant, metastasis,

#1215 Describing NENs: Just Clinical/Biologic Features or Actual Prognostic Factors?

Introduction: Neuroendocrine neoplasias (NENs) are a rare group of diseases, with several possible locations and manifestations, often representing a challenging diagnosis. It is essential to improve tools that accurately predict aggressiveness and prognosis.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Ribeiro C

Authors: Ribeiro C, Gomes F, Semedo M, Filipe F, Oliveira S,

Keywords: Neuroendocrine neoplasias, prognosis,

#1126 Long-Term Follow-Up and Survival Data in Progressing Advanced Midgut Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) is an effective treatment option for advanced Neuroendocrine Tumours (NET), however long term survival data is lacking.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Oliveira A, Pencharz D, Navalkissoor S, Quigley A,

Keywords: PRRT, PFS, OS,

#368 The Role of Image and Chromogranin A Level at Diagnosis: A Portuguese Review of 19 Patients

Introduction: Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms. Biochemical neuroendocrine markers offer high sensitivity in establishing the diagnosis and, if correlated with image assessment, can provide important prognostic information.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Barata P, Oliveira S, Leite S, Custódio M, Sousa M,

Keywords: neuroendocrine tumor, chromogranin, octreoscan,